Gene Query: PDCL

Dataset Description Geneva Score
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 20.67
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 18.13
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 10.6
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.52
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 8.39
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.31
Tracking distinct RNA populations using efficient and reversible covalent chemistry 8.27
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 8.18
LIN28A Over-expression RNAseq 7.99
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.35
Genome-wide analysis of the Integrator complex (HTS) 7.3
Genome-wide analysis of the Integrator complex 7.3
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 6.79
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 6.76
Effect of drugs on transcriptomic profiles 6.73
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.25
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 6.06
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.92
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.63
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 5.54
scRNASeq analysis of cycling cardiomyocytes 5.48
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.46
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 5.45
Cleavage Factor Im as a key regulator of 3’ UTR length 5.37
The human blood-nerve barrier transcriptome 5.37
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.22
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 5.06
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.06
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.81
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.8
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.79
IL-33 activates tumor stroma to promote intestinal polyposis 4.76
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.71
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.71
Transcriptome analysis of Zika infected neural stem cells 4.6
Zika infected neural stem cells 4.6
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.5
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 4.5
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 4.5
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.48
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.4
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.38
RNAseq Study in CC-671 Treated Cal-51 Cells 4.38
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 4.36
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.33
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 4.32
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 4.32
Ribosomal footprinting of MDA-Parental and MDA-LM2 4.3
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 4.3
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 4.28
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.26
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.26
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.26
Ribosomal footprinting of CN34-Parental and CN34-LM1a 4.21
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.19
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 4.15
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.15
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 4.09
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.05
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.92
SUV420H2 knockdown in PANC-1 3.87
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.87
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.84
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 3.83
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.81
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.81
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.77
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.77
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 3.77
Expression profiling of etoposide-induced senescent cells 3.77
CROP-Seq in Primary Human T Cells 3.74
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 3.72
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.72
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.72
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 3.71
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 3.68
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 3.68
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.66
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.62
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.61
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 3.58
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 3.57
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.57
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 3.51
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.49
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.47
RNAseq of HEK293 cells after Chtop knockdown 3.47
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.45
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 3.44
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.42
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.39
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 3.38
Differential analysis of gene regulation at transcript resolution by RNA-Seq 3.35
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 3.35
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.35
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.34
Endothelial gene expression analysis 3.34
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.32
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.32
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.26
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.25
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 3.23
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 3.21
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.19
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 3.18
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.18
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.17
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.17
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.16
AMPK signaling for naïve pluripotency 3.16
AMPK signaling for naïve pluripotency [Hs] 3.16
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 3.16
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.1
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.04
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.01
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.96
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.96
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.94
RNA-seq analysis to identify the genes regulated by p53-SET interplay 2.9
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 2.89
SLAM-seq for K562 endogenous mRNA decay 2.86
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.85
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.83
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.82
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 2.81
Exploring the RNA landscape of endothelial exosomes 2.81
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.78
Oncogenic roles of ARID5B in T-ALL 2.78
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.78
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.78
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 2.77
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.77
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.76
Overexpression of NFIB and YBX1 in MCF-7 cells 2.76
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.75
RNA expression analysis upon JMJD1C depletion 2.75
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.75
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 2.75
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.75
Single-Cell Genotyping of Transcriptomes 2.75
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.74
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.74
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.73
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.73
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.73
SLIGRL-induced gene expression changes in NHEK cells 2.71
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 2.69
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 2.69
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.68
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 2.67
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.67
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 2.66
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.65
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.65
mRNA recovered upon RNF219 IP. [RNA-IP] 2.64
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.63
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 2.61
mRNA expression profile of Lymphocytes 2.59
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 2.56
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.56
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.55
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.54
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.53
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 2.52
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.51
Evolution of a transcriptional regulator from a transmembrane nucleoporin 2.51
RNA-seq in HepG2 and IMR90 cells 2.51
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 2.5
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 2.5
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.49
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 2.48
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 2.47
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.46
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 2.45
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.45
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.45
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.43
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.42
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 2.42
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 2.42
Effect of PRDM11 depletion in U2932 cells 2.41
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.39
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.39
The evolution of N6-methyladenosine in primates 2.38
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 2.38
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.37
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.36
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.36
Unique features and clinical importance of acute alloreactive immune responses 2.36
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 2.35
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.34
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 2.29
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 2.28
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.27
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 2.25
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.24
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.24
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.21
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.21
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 2.2
Genome wide miR-191 target profile determined by RIP and gene expression profiling 2.2
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 2.2
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 2.2
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.2
Real-time observation of light-controlled transcription in living cells 2.19
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.19
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.18
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 2.18
Neonatal and adult human testis defined at the single-cell level 2.18
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.17
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.17
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.16
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.16
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 2.14
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.13
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 2.13
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.12
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.1
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.1
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.08
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.08
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.08
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.06
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 2.04
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.04
Nucleoporin-mediated regulation of cell identity genes 2.03
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.0
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.0
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.99
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.98
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 1.96
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.95
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.95
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.94
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 1.94
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 1.94
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.91
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 1.9
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.89
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 1.88
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 1.88
RNA-Seq from human ILC transitional populations 1.87
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.87
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.86
RNA Seq of HMVEC under hypoxia 1.86
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 1.86
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 1.86
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 1.86
m6A-dependent regulation of messenger RNA stability 1.85
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.85
PRDM1 inhibits proliferation of human colon cancer organoids 1.85
Accurate annotation of human protein-coding small open reading frames 1.84
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.83
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.83
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 1.83
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.83
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 1.82
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 1.82
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.82
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 1.82
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.81
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.81
Illumina Total RNA-seq in HeLa 1.8
PTHrP overexpression in MCF7 cells 1.8
Transcriptional landscape changes during human embryonic stem cell derivation 1.8
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 1.79
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 1.78
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.78
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 1.74
ETV7 and interferon response 1.74
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 1.74
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 1.74
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.73
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.73
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.73
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.71
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.71
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 1.69
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.69
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.68
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.68
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.68
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.67
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.65
RNA seq comparison between scrambled and shGRP78 cells 1.64
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 1.63
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.62
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 1.62
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 1.62
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.61
N6-methyladenine DNA Modification in Glioblastoma 1.61
RNA-seq differential expression studies: more sequence, or more replication? 1.6
Expression by CD133+ cells isolated from the adult human exocrine pancreas 1.6
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.59
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.59
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.59
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.59
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.58
Morphological and molecular characterization of human dermal lymphatic collectors 1.57
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.55
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 1.54
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.54
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.54
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 1.53
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.53
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.51
Functional significance of the HIV-1 Tat signature amino acid residues 1.51
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.5
Hepatocyte maturation 1.5
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 1.48
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.47
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.47
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 1.45
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.44
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.42
RNA-seq analyisis of PUM2 knockout cells 1.42
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.4
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.4
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.4
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.39
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.39
Identification of renal resident macrophages across species [C1] 1.39
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.38
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.37
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.37
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.37
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.35
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.35
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.35
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.33
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.32
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.32
Transcriptomic profiling of human peripheral blood-derived mast cells 1.32
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.3
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.3
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.29
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.28
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 1.27
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.26
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.25
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.23
RNA-seq of cancer cell lines treated with T-025 1.21
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.19
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 1.19
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.17
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.16
Impact on erythroid progenitor type on erythroid differntiation 1.16
Transcriptome-wide modulation of splicing by the exon junction complex 1.16
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.14
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.14
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.1
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.08
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.08
Ribosome profiling upon inhibition of eIF4A 1.08
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 1.08
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.08
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.08
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.07
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.07
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.07
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.05
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 1.03
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.03
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.02
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.02
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.02
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.02
O-glcnAc reprograms cellular energetics 1.01
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 1.0
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.0
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 1.0
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.99
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.98
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.96
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.94
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.93
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.92
Identification of renal resident macrophages across species 0.92
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.91
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.9
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.9
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.9
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.89
Global transcriptome analysis of WT versus HEB-/- hESCs 0.89
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 0.89
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.88
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.88
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.85
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.85
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.81
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.81
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.81
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.8
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.8
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.79
KSDM1b Role in Ewing Sarcoma 0.78
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.77
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 0.77
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.77
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.77
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.76
Landscape and variation of RNA secondary structure across the human transcriptome 0.75
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.74
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.74
FOXP1 orchestration of ASD-relevant signaling pathways. 0.74
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.73
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.73
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.72
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.7
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.7
UBC9 knockdown in bladder cancer T24 cell lines 0.7
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.7
Identification of a LIF-responsive replication-competent human β cell 0.68
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.65
Leucegene: ALL sequencing 0.63
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.62
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.61
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.6
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.6
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.59
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.59
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.59
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.58
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.56
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.56
Effect of from Human Umbilical Vein Endothelial Cells 0.55
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.55
Expression profiling of MCF-7 cells with treatment of TCDD 0.55
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 0.53
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.53
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.53
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.52
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.52
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.51
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.5
Regulation of poly(A) tail and translation during the somatic cell cycle 0.5
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.48
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.48
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.47
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.45
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.45
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.45
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.45
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.44
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.44
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.43
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.43
Human Treg NaCl stimulation 0.42
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.42
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.41
siRNA-mediated knockdown 0.41
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.39
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.39
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.38
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.38
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.35
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.33
p53 activity results in DNA replication fork processivity 0.33
Gene expression changes due to PARP knockdown in human cells 0.31
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.3
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.29
RNA-seq data 0.29
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.29
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.28
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.28
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.28
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.28
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.28
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.27
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.26
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.26
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.26
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.25
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.25
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.25
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.24
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.19
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.16
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.15
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.15
Effect of nuclear IL-33 on gene expression 0.14
High-resolution comparative analysis of great ape genomes 0.11
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.11
Role of FGFR1 in neuronal devlopment 0.1
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.09
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.09
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.08
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.07
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.06
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.06
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.06
RNA-Seq of the corpus callosum from 12 individuals 0.05
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.04
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.03
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.01
Modulation of nonsense-mediated decay by rapamycin 0.01
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation